Micurx

This Phase 3 trial tests a new antibiotic called contezolid against a standard one (linezolid) for moderate to severe diabetic foot infections. About 865 adults with diabetes and a foot infection will receive either drug for 2 to 4 weeks. The goal is to see if the new drug works …